EXAS Stock Pulls Back Gains Despite Bullish Calls For Cologuard 2.0 | Investor's Business Daily – Investor's Business Daily

Business News

  1. EXAS Stock Pulls Back Gains Despite Bullish Calls For Cologuard 2.0 | Investor’s Business Daily  Investor’s Business Daily
  2. Exact Sciences’ shares pop on positive Cologuard trial results  CNBC Television
  3. Exact Sciences pads the case for next-gen Cologuard test with improved study results  FierceBiotech
  4. Why Exact Sciences Stock Is Moving Higher After Hours – Exact Sciences (NASDAQ:EXAS)  Benzinga
  5. Exact Sciences touts accuracy of updated Cologuard cancer test, but experts want more data  STAT
  6. View Full Coverage on Google News

Source: Business News

/by